V

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Associate Director - Quantitative System Pharmacology

Quantitative Biology & BiostatisticsUpdated on Nov 11
Full-timeWaltham, MA, USA

About the Job

Requirements

  • Requires a PhD degree or equivalent with a minimum of 6+ years of combined academic and biotechnology or pharmaceutical experience in QSP/T, (m)PBPK, mathematics, chemical/biomedical engineering, physics, and/or Translational Sciences, including experience with therapeutic antibodies.
  • Demonstrated success contributing preclinical or translational, and clinical pharmacology-related aspects across different stages of programs.
  • Prior experience in QSP(T) with in-depth knowledge of mechanistic modelling and data interpretation, as well as a track record supporting this experience.
  • Independent hands-on proficiency in MATLAB/Simbiology, MoBI, GastroPlus/PK-Sim, R, or other software.
  • Ability to effectively present ideas and data interpretation for complex quantitative clinical concepts in both written and oral communication.
  • Proficient with the Microsoft Office suite, including Word, PowerPoint, Excel, Outlook, and SharePoint.

Responsibilities

  • Understand and execute the fit-for-purpose Model-informed Drug Development strategy to accelerate program advancement.
  • Provide experience with QSP or (m)PBPK modeling in autoimmune or inflammation for biologicals, including monoclonal antibodies or other modalities, and bring forward combination drug approaches leveraging QSP models to advance clinical trials.
  • Provide (semi)mechanistic modeling and simulation support and expertise to assigned programs.
  • Survey literature to gain a fit-for-purpose understanding of preclinical and/or clinical physiology, pathology, and disease state to enable quantitative systems pharmacology modeling and simulation.
  • Work closely with biologists, discovery chemistry, clinical pharmacologists, pharmacometricians, and other functions to improve understanding of disease mechanisms, modalities, and monotherapy and combination therapy.
  • Maintain quantitative systems pharmacology expertise in the field.
  • Communicate QSP/(m)PBPK results across the program team.

About the Company

Viridian Therapeutics

Develops miRNA-targeting therapies for autoimmune diseases

Viridian Therapeutics discovers and develops therapies that target microRNA (miRNA) pathways to treat autoimmune diseases, with a focus on thyroid eye disease. The company uses monoclonal antibody technology aimed at the IGF-1 receptor (IGF-1R) pathway to modulate disease biology. Its product approach integrates miRNA biology with antibody engineering to create treatments that intervene in autoimmune processes. The company differentiates itself by combining miRNA-targeting strategies with IGF-1R–focused monoclonal antibodies, operating in the clinical-stage space and concentrating on rare thyroid-related autoimmune conditions. Its goal is to advance clinical candidates through development toward regulatory approval and eventual market launch for patients who suffer from these diseases.

Company size
201-500
Company stage
IPO
Headquarters
Waltham, MA
Founded
2007

Recently Posted Jobs

Explore more opportunities at Viridian Therapeutics

See more jobs